Building a Comparative FDA May Not Lead to Effectiveness
A recent article in the Journal of the American Medical Association (JAMA) discusses how to “Build Comparative Efficacy and…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Senate to Vote on Changes to Reconciliation Package – List of…
This afternoon the Senate will be holding 8+ hours of debate on amendments offered by the Republicans to the House Reconciliation…
Physician Payment Sunshine: Marketing Research Association Declares a…
While insurance companies, pharmaceutical and medical device makers, and doctors are still trying to determine how the newly…
NIH Transparency: Research Over Bureaucracy
This past January, Senator Charles Grassley (R-IA) sent letters to Francis S. Collins, M.D., Ph.D., Director of the National…
Senate Aging Committee on Pharmaceutical Pricing
At the Senate Special Committee on Aging Hearing last week, Senators focused on “Seniors Feeling the Squeeze: Rising Drug Prices…
Stanford Ban’s Volunteer Faculty from Working with Industry
Although the Stanford University School of Medicine already has one of the most comprehensive policies in the country governing…
Health Care Reform: The Price of Reconciliation
While most of us were sleeping last night, the United States House of Representatives approved the Senate Health Care Bill. In a…
Physician Payment Sunshine Provisions: Patient Protection Affordable Care…
Tonight the House of Representatives passed the senate bill the Patient Protection Affordable Care Act and a Reconciliation…
NEJM Letters to the Editor: Underplaying the Value of Industry Support of…
An article last year in the New England Journal of Medicine (NEJM) focused on “The agenda for continuing medical education —…
Harrington Relationships with Industry: Research, CME, Focus on Solutions
A recent lecture from Robert A. Harrington MD, FACC, focused on the "Relationships with Industry: Effects on the Academic…